Cargando…

Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review

Cannabidiol (CBD) is a non-intoxicating cannabinoid compound with diverse molecular targets and potential therapeutic effects, including effects relevant to the treatment of psychiatric disorders. In this scoping review, we sought to determine the extent to which sex and gender have been considered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matheson, Justin, Bourgault, Zoe, Le Foll, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599539/ https://www.ncbi.nlm.nih.gov/pubmed/36291671 http://dx.doi.org/10.3390/biom12101462

Ejemplares similares

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
por: Matheson, Justin, et al.
Publicado: (2021)

Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences
por: Matheson, Justin, et al.
Publicado: (2023)

Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample
por: Bourgault, Zoe, et al.
Publicado: (2022)

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
por: Matheson, Justin, et al.
Publicado: (2020)

Cannabidiol in Dentistry: A Scoping Review
por: David, Carla, et al.
Publicado: (2022)

Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health
por: Matheson, Justin, et al.
Publicado: (2020)

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
por: Vitale, Rosa Maria, et al.
Publicado: (2021)

Implementation and Preliminary Evaluation of a 12-Week Cognitive Behavioural and Motivational Enhancement Group Therapy for Cannabis Use Disorder
por: Trick, Leanne, et al.
Publicado: (2023)

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018)

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
por: Scarante, Franciele F., et al.
Publicado: (2021)

Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders
por: Williams, Olivia O. F., et al.
Publicado: (2021)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

Association between ABCB1 rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults
por: Matheson, Justin, et al.
Publicado: (2022)

The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience
por: Rubin-Kahana, Dafna Sara, et al.
Publicado: (2022)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Sex Differences in Tryptophan Metabolism: A Systematic Review Focused on Neuropsychiatric Disorders
por: Pais, Mariana Lapo, et al.
Publicado: (2023)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
por: Russell, Cayley, et al.
Publicado: (2023)

Using the tools of genetic epidemiology to understand sex differences in neuropsychiatric disorders
por: Merikangas, Alison K., et al.
Publicado: (2020)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
por: Markowitz, John S., et al.
Publicado: (2022)

Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
por: Fabris, Débora, et al.
Publicado: (2022)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies
por: Xiao, Ke Bin, et al.
Publicado: (2023)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats
por: Rozental, Aaron J., et al.
Publicado: (2022)

Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review
por: Chan, John Zewen, et al.
Publicado: (2021)

Effects of Cannabidiol on Locomotor Activity
por: Calapai, Fabrizio, et al.
Publicado: (2022)

Design, Use, and Effects of Sex Dolls and Sex Robots: Scoping Review
por: Döring, Nicola, et al.
Publicado: (2020)

Sex-biased cellular signaling: molecular basis for sex differences in neuropsychiatric diseases
por: Valentino, Rita J., et al.
Publicado: (2016)

Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
por: Silote, Gabriela P., et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
por: Gamble, Lauri-Jo, et al.
Publicado: (2018)

Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge
por: Di Salvo, Alessandra, et al.
Publicado: (2023)

Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders
por: Shobeiri, Parnian, et al.
Publicado: (2022)

The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review
por: Vanclooster, Stephanie, et al.
Publicado: (2022)

Sex differences in neurology: a scoping review
por: Moores, Ginette, et al.
Publicado: (2023)

Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
por: Murphy, Thomas, et al.
Publicado: (2020)

Cannabidiol and Intestinal Motility: a Systematic Review
por: Story, Galaxie, et al.
Publicado: (2023)

Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
por: Polidoro, Dakir, et al.
Publicado: (2022)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
por: della Rocca, Giorgia, et al.
Publicado: (2023)

Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses
por: Eichler, Fabienne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqvgrrbu6mjv9g90bfr79poamd